FrancophonIA/ELRC3.0 huggingface dataset:
English: EU/1/00/132/031 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/132/032 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/132/034 (12 pens, 12 injection needles and 24 cleansing swabs)
Icelandic: EU/1/00/132/031 (l lyfjapenni, 1 nál og 2 hreinsiþurrkur) EU/1/00/132/032 (4 lyfjapennar, 4 nálar og 8 hreinsiþurrkur) EU/1/00/132/034 (12 lyfjapennar, 12 nálar og 24 hreinsiþurrkur)
English: Each vial provides 50 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Hvert hettuglas gefur 50 míkróg/0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: Each vial provides 150 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Hvert hettuglas gefur 150 míkróg/0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: Powder and solvent for solution for injection in pre-filled pen 1 pen (CLEARCLICK), 1 injection needle and 2 cleansing swabs 4 pens (CLEARCLICK), 4 injection needles and 8 cleansing swabs 12 pens (CLEARCLICK), 12 injection needles and 24 cleansing swabs 150 micrograms/0.5 ml
Icelandic: Stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna l lyfjapenni (CLEARCLICK), 1 nál og 2 hreinsiþurrkur 4 lyfjapennar (CLEARCLICK), 4 nálar og 8 hreinsiþurrkur 12 lyfjapennar (CLEARCLICK), 12 nálar og 24 hreinsiþurrkur 150 míkróg/0,5 ml
English: ViraferonPeg 80 micrograms powder for injection peginterferon alfa-2b
Icelandic: ViraferonPeg 80 míkróg stungulyfsstofn peginterferon alfa-2b s.c.
English: ViraferonPeg 100 micrograms powder for injection peginterferon alfa-2b
Icelandic: ViraferonPeg 100 míkróg stungulyfsstofn peginterferon alfa-2b s.c.
English: One pre-filled pen contains a sufficient amount of peginterferon alfa-2b to provide 120 micrograms in 0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Einn áfylltur lyfjapenni inniheldur nægilegt magn af peginterferon alfa-2b sem gefur 120 míkróg í 0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: Luxembourg/Luxemburg MSD Belgium BVBA/SPRL Tel: +32(0)27766211 dpoc_belux@merck.com
Icelandic: +32(0)27766211 dpoc_belux@merck.com
English: EU/1/00/132/023 (4 vials of powder, 4 ampoules of solvent) EU/1/00/132/024 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
Icelandic: EU/1/00/132/024 (4 hettuglös af stungulyfsstofni, 4 lykjur af leysi, 4 sprautur, 8 nálar og 4 hreinsiþurrkur)
English: - have ever had a heart attack or a heart problem.
Icelandic: - ef þú ert með eða hefur verið með lifrarbólgu
English: Select the injection site.
Icelandic: Veldu stungustað.
English: Each vial provides 100 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Hvert hettuglas gefur 100 míkróg/0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: ViraferonPeg 150 micrograms powder and solvent for injection peginterferon alfa-2b
Icelandic: ViraferonPeg 150 míkróg stungulyfsstofn og leysir, lausn peginterferon alfa-2b
English: ViraferonPeg 120 micrograms - vial of powder
Icelandic: ViraferonPeg 120 míkróg - hettuglas af stungulyfsstofni
English: 11 months) + ribavirin (1,000/1,200 mg/day), (n = 514).
Icelandic: - ViraferonPeg (1,5 míkróg/kg/viku) + ríbavírin (800 mg/dag), (n = 511).
English: ViraferonPeg is indicated in a combination regimen with ribavirin for the treatment of children 3 years of age and older and adolescents, who have chronic hepatitis C, previously untreated, without liver decompensation, and who are positive for HCV-RNA.
Icelandic: ViraferonPeg er ætlað til notkunar í samsettri meðferð með ríbavírini til meðferðar á börnum 3 ára og eldri og unglingum með langvinna lifrarbólgu
English: Approximately 21 % of children treated with ViraferonPeg/ribavirin combination therapy developed increase in thyroid stimulating hormone (TSH).
Icelandic: 21% barna sem fengu samsetta meðferð með ViraferonPeg/ríbavírini.
English: Each pre-filled pen provides 100 micrograms/0.5 ml of solution when reconstituted as recommended.
Icelandic: Hver áfylltur penni inniheldur 100 míkróg/0,5 ml lausn þegar lyfið hefur verið leyst upp samkvæmt leiðbeiningum.
English: - pulmonary fibrosis (scarring of the lungs).
Icelandic: Stungulyfsstofn (duft):
English: o With zidovudine or stavudine, it is not certain if ribavirin will change the way these medicines work.
Icelandic: o Ekki er víst hvort ríbavírin, þegar það er gefið ásamt zídovúdíni eða stavúdíni, breyti verkunarhætti þessara lyfja.
English: Table 13 Sustained virological response based on genotype after ViraferonPeg in combination with Ribavirin in HCV/HIV Co-infected patients Study 1
Icelandic: Tafla 13 Viðvarandi veirufræðileg svörun, flokkað er eftir arfgerð, eftir samsetta meðferð með ViraferonPeg og ríbavírini, hjá sjúklingum með samhliða HCV- og HIVsýkingu
English: ViraferonPeg 50 micrograms powder for injection peginterferon alfa-2b
Icelandic: ViraferonPeg 50 míkróg stungulyfsstofn peginterferon alfa-2b s.c.
English: ViraferonPeg is supplied as: - 1 pre-filled pen (CLEARCLICK) containing powder and solvent for solution for injection, 1 needle ("Push-On Needle"), 2 cleansing swabs; - 4 pre-filled pens (CLEARCLICK) containing powder and solvent for solution for injection, 4 needles ("Push-On Needle"),
Icelandic: - 1 áfylltur lyfjapenni (CLEARCLICK) sem inniheldur stungulyfsstofn og leysi, lausn, 1 nál („Nál sem þrýst er á pennann“), 2 hreinsiþurrkur.
English: Eye pain
Icelandic: Að auki fengu
English: - pain in joints and muscles, muscle and bone pain.
Icelandic: Vöðvakreppa, vöðvakippir
English: One pre-filled pen contains a sufficient amount of peginterferon alfa-2b to provide 80 micrograms in 0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Einn áfylltur lyfjapenni inniheldur nægilegt magn af peginterferon alfa-2b sem gefur 80 míkróg í 0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: Carton 150 micrograms powder and solvent for solution for injection in pre-filled pen
Icelandic: Askja 150 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna
English: a: p value based on Cochran-Mantel Haenszel Chi square test. b: p value based on chi-square test. c: subjects < 75 kg received 100 µg/week ViraferonPeg and subjects ≥ 75 kg received 150 µg/week ViraferonPeg.
Icelandic: a: p-gildi byggt á Cochran-Mantel Haenszel kí-kvaðratprófi.
English: What you need to know before you use ViraferonPeg
Icelandic: Áður en byrjað er að nota ViraferonPeg
English: Pen label - ViraferonPeg 100 micrograms powder and solvent for solution for injection in prefilled pen
Icelandic: ViraferonPeg 100 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna
English: ViraferonPeg 120 micrograms powder and solvent for solution for injection in pre-filled pen peginterferon alfa-2b
Icelandic: ViraferonPeg 120 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna peginterferon alfa-2b
English: Needle shield
Icelandic: B. FYLGISEÐILL
English: Children and adolescents: not applicable
Icelandic: Börn og unglingar:
English: Pen label - ViraferonPeg 50 micrograms powder and solvent for solution for injection in prefilled pen
Icelandic: ViraferonPeg 50 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna
English: EU/1/00/132/008 (4 vials of powder, 4 ampoules of solvent) EU/1/00/132/009 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
Icelandic: EU/1/00/132/009 (4 hettuglös af stungulyfsstofni, 4 lykjur af leysi, 4 sprautur, 8 nálar og 4 hreinsiþurrkur)
English: Hydration
Icelandic: Lyfhrif
English: Pen label - ViraferonPeg 120 micrograms powder and solvent for solution for injection in prefilled pen
Icelandic: ViraferonPeg 120 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna
English: Reduce ViraferonPeg to one-half dose if:
Icelandic: ViraferonPeg er fáanlegt sem:
English: Note 1: In adult patients 1
Icelandic: Hjá fullorðnum sjúklingum sem eru
English: - have heart disease that has not been well controlled during the past 6 months.
Icelandic: Sjúklingar sem ekki hafa verið meðhöndlaðir áður
English: One pre-filled pen contains a sufficient amount of peginterferon alfa-2b to provide 100 micrograms in 0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Einn áfylltur lyfjapenni inniheldur nægilegt magn af peginterferon alfa-2b sem gefur 100 míkróg í 0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: - changes in taste, diarrhoea, stomach upset, oral pain, - fainting, palpitations (pounding heart beat), rapid heart rate, flushing, nosebleed, - sores in mouth, scaling lips and clefts in the corners of the mouth, rash, redness of skin, itching, eczema (inflamed, red, itchy and dryness of the skin with possible oozing lesions), acne, - back pain, muscle and bone pain, limb pain, dryness, pain, rash, irritation or itching at the site of injection.
Icelandic: - sjálfskaðahugleiðingar eða - tilraunir, árásargjörn hegðun, æsingur, reiði, skapbreytingar, taugaóstyrkur eða eirðarleysi, þunglyndi, kvíði, erfiðleikar með að festa svefn eða ná samfelldum svefni, tilfinningalegt ójafnvægi, lítil svefngæði, syfja, skert athygli, - breytt bragðskyn, niðurgangur, magaóþægindi, verkur í munni - yfirlið, hjartsláttarónot (þungur hjartsláttur), hraður hjartsláttur, andlitsroði, blóðnasir - sár í munni, flagnaðar varir og sprungur í munnvikum, útbrot, roði í húð, kláði, exem (bólga, roði, kláði og þurrkur í húð hugsanlega ásamt vætlandi sárum), þrymlabólur - bakverkur, vöðva- og beinverkir, verkir í útlimum, þurrkur, verkur, útbrot, erting eða kláði á stungustað.
English: Mitochondrial toxicity
Icelandic: Eiturverkun á hvatbera
English: Patients co-infected with HIV and receiving Highly Active Anti-Retroviral Therapy (HAART) may be at increased risk of developing lactic acidosis.
Icelandic: Sjúklingar með langt genginn lifrarsjúkdóm, sem fá öfluga andretróveirumeðferð geta verið í aukinni hættu á að lifrarstarfsemi versni.
English: ViraferonPeg 100 micrograms powder and solvent for injection peginterferon alfa-2b
Icelandic: ViraferonPeg 100 míkróg stungulyfsstofn og leysir, lausn peginterferon alfa-2b
English: ViraferonPe g strength (g/0.5 ml)
Icelandic: ViraferonPegstyrkur (míkróg/0,5 ml)
English: All patients should have a baseline eye examination.
Icelandic: Allir sjúklingar ættu að gangast undir augnskoðun áður en meðferð hefst.
English: ViraferonPeg 100 micrograms - vial of powder
Icelandic: ViraferonPeg 100 míkróg - hettuglas af stungulyfsstofni
English: EU/1/00/132/013 (4 vials of powder, 4 ampoules of solvent) EU/1/00/132/014 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
Icelandic: EU/1/00/132/014 (4 hettuglös af stungulyfsstofni, 4 lykjur af leysi, 4 sprautur, 8 nálar og 4 hreinsiþurrkur)
English: EU/1/00/132/018 (4 vials of powder, 4 ampoules of solvent) EU/1/00/132/019 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
Icelandic: EU/1/00/132/019 (4 hettuglös af stungulyfsstofni, 4 lykjur af leysi, 4 sprautur, 8 nálar og 4 hreinsiþurrkur)
English: Carton 80 micrograms powder and solvent for solution for injection in pre-filled pen
Icelandic: Askja 80 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna
English: One pre-filled pen contains a sufficient amount of peginterferon alfa-2b to provide 50 micrograms in 0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Einn áfylltur lyfjapenni inniheldur nægilegt magn af peginterferon alfa-2b sem gefur 50 míkróg í 0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: ViraferonPeg (100 or c µg/week) + ribavirin
Icelandic: ViraferonPeg (100 eða c míkróg/viku) + ríbavírin (8001.200 mg)
English: One pre-filled pen contains a sufficient amount of peginterferon alfa-2b to provide 150 micrograms in 0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Einn áfylltur lyfjapenni inniheldur nægilegt magn af peginterferon alfa-2b sem gefur 150 míkróg í 0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: ViraferonPeg 80 micrograms powder and solvent for solution for injection peginterferon alfa-2b
Icelandic: ViraferonPeg 80 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna peginterferon alfa-2b
English: ViraferonPeg 50 micrograms powder and solvent for injection peginterferon alfa-2b
Icelandic: ViraferonPeg 50 míkróg stungulyfsstofn og leysir, lausn peginterferon alfa-2b
English: Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Icelandic: Allar nánari leiðbeiningar er að finna í viðauka með fylgiseðli.
English: Reminder to adult patients prescribed combination therapy of this medicine, boceprevir and ribavirin: Please read the “Possible side effects” section of these Package Leaflets.
Icelandic: Áminning fyrir fullorðna sjúklinga sem er ávísað samsettri meðferð með þessu lyfi, ásamt boceprevíri og ríbavírini:
English: Paediatric population (bitherapy only) - Duration of treatment
Icelandic: Börn (tveggja lyfja meðferð eingöngu)
English: - changes in taste, diarrhoea, stomach upset, oral pain, - fainting, palpitations (pounding heart beat), rapid heart rate, flushing, nosebleed, - sores in mouth, scaling lips and clefts in the corners of the mouth, rash, redness of skin, itching,
Icelandic: - lystarleysi, sundl, höfuðverkur, uppköst, ógleði, magaverkur - hárlos, húðþurrkur, lið- og vöðvaverkir, roði á stungustað - skapstyggð, þreyta, lasleikatilfinning, verkir, kuldahrollur, hiti, flensulík einkenni, þróttleysi,
English: Carton 120 micrograms powder and solvent for solution for injection in pre-filled pen
Icelandic: Askja 120 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna
English: Visual disturbance, vision blurred, photophobia, conjunctivitis, eye irritation, lacrimal disorder, eye pain, dry eye
Icelandic: Sjóntruflanir, þokusýn, ljósfælni, tárubólga, erting í augum, kvilli í tárakirtlum, augnverkur, augnþurrkur
English: - have had severe heart problems.
Icelandic: hraður hjartsláttur.
English: Powder and solvent for solution for injection in pre-filled pen 1 pen (CLEARCLICK), 1 injection needle and 2 cleansing swabs 4 pens (CLEARCLICK), 4 injection needles and 8 cleansing swabs 12 pens (CLEARCLICK), 12 injection needles and 24 cleansing swabs 120 micrograms/0.5 ml
Icelandic: Stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna l lyfjapenni (CLEARCLICK), 1 nál og 2 hreinsiþurrkur 4 lyfjapennar (CLEARCLICK), 4 nálar og 8 hreinsiþurrkur 12 lyfjapennar (CLEARCLICK), 12 nálar og 24 hreinsiþurrkur 120 míkróg/0,5 ml
English: Package inserts of theophylline should be referred to when co-administering with the product (ViraferonPeg)
Icelandic: Sjá fylgiseðil fyrir teófyllín við samhliða gjöf teófyllíns og lyfsins (PegIntron)
English: Powder and solvent for solution for injection in pre-filled pen 1 pen (CLEARCLICK), 1 injection needle and 2 cleansing swabs 4 pens (CLEARCLICK), 4 injection needles and 8 cleansing swabs 12 pens (CLEARCLICK), 12 injection needles and 24 cleansing swabs 80 micrograms/0.5 ml
Icelandic: Stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna l lyfjapenni (CLEARCLICK), 1 nál og 2 hreinsiþurrkur 4 lyfjapennar (CLEARCLICK), 4 nálar og 8 hreinsiþurrkur 12 lyfjapennar (CLEARCLICK), 12 nálar og 24 hreinsiþurrkur 80 míkróg/0,5 ml
English: ViraferonPeg 50 micrograms - vial of powder
Icelandic: ViraferonPeg 50 míkróg - hettuglas af stungulyfsstofni
English: Each pre-filled pen provides 120 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Hver áfylltur lyfjapenni gefur 120 míkróg/0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: Powder and solvent for solution for injection in pre-filled pen 1 pen (CLEARCLICK), 1 injection needle and 2 cleansing swabs 4 pens (CLEARCLICK), 4 injection needles and 8 cleansing swabs 12 pens (CLEARCLICK), 12 injection needles and 24 cleansing swabs 100 micrograms/0.5 ml
Icelandic: Stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna l lyfjapenni (CLEARCLICK), 1 nál og 2 hreinsiþurrkur 4 lyfjapennar (CLEARCLICK), 4 nálar og 8 hreinsiþurrkur 12 lyfjapennar (CLEARCLICK), 12 nálar og 24 hreinsiþurrkur 100 míkróg/0,5 ml
English: ViraferonPeg 150 micrograms powder and solvent for solution for injection peginterferon alfa-2b
Icelandic: ViraferonPeg 150 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna peginterferon alfa-2b
English: SVR after treatment of chronic HCV with ViraferonPeg (with or without ribavirin) results in long-term clearance of the virus providing resolution of the hepatic infection and clinical “cure” from chronic HCV.
Icelandic: Viðvarandi veirufræðileg svörun eftir meðferð við langvinnri lifrarbólgu C með ViraferonPeg (með eða án ríbavírins) leiddi til langtímaveiruútrýmingar, hjöðnunar lifrarsýkingarinnar og klínísks „bata“ á langvinnri lifrarbólgu C. Þetta útilokar þó ekki lifrarsjúkdóma hjá sjúklingum með skorpulifur (þ.m.t. lifrarkrabbamein).
English: Growth and development (children and adolescents) During the course of therapy lasting up to 48 weeks in patients ages 3 through 17 years, weight loss and growth inhibition were common.
Icelandic: Meðan á meðferð stóð, í allt að 48 vikur, var þyngdartap og vaxtarskerðing algeng hjá sjúklingum frá 3 til 17 ára aldurs.
English: Each pre-filled pen provides 150 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Hver áfylltur lyfjapenni gefur 150 míkróg/0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: Clear and colourless solvent.
Icelandic: Tær og litlaus leysir.
English: *, dry skin *, rash
Icelandic: *, húðþurrkur
English: Each pre-filled pen provides 80 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Hver áfylltur lyfjapenni gefur 80 míkróg/0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: EU/1/00/132/005 (6 vials of powder, 6 ampoules of solvent) EU/1/00/132/026 (12 vials of powder, 12 ampoules of solvent, 12 injection syringes, 24 injection needles and 12 cleansing swabs)
Icelandic: EU/1/00/139/005 (6 hettuglös af stungulyfsstofni, 6 lykjur af leysi) EU/1/00/139/026 (12 hettuglös af stungulyfsstofni, 12 lykjur af leysi, 12 sprautur, 24 nálar og 12 hreinsiþurrkur)
English: Chronic Hepatitis C Subjects (N=22)
Icelandic: C (N=22)
English: Powder and solvent for solution for injection in pre-filled pen 1 pen (CLEARCLICK), 1 injection needle and 2 cleansing swabs 4 pens (CLEARCLICK), 4 injection needles and 8 cleansing swabs 12 pens (CLEARCLICK), 12 injection needles and 24 cleansing swabs 50 micrograms/0.5 ml
Icelandic: Stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna l lyfjapenni (CLEARCLICK), 1 nál og 2 hreinsiþurrkur 4 lyfjapennar (CLEARCLICK), 4 nálar og 8 hreinsiþurrkur 12 lyfjapennar (CLEARCLICK), 12 nálar og 24 hreinsiþurrkur 50 míkróg/0,5 ml
English: A small volume is lost during preparation of this medicine for injection and when the dose is measured and injected.
Icelandic: Meðan blöndun lyfsins fyrir inndælingu fer fram og þegar skammturinn er mældur og gefinn nýtist ekki örlítið rúmmál.
English: Carton 100 micrograms powder and solvent for solution for injection in pre-filled pen
Icelandic: Askja 100 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna
English: Carton 50 micrograms powder and solvent for solution for injection in pre-filled pen
Icelandic: Askja 50 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna
English: nd dose reduction of ribavirin is by an additional 200 mg/day.
Icelandic: Ef þörf krefur er skammtur ríbavírins minnkaður í 2. skipti um 200 mg/sólarhring til viðbótar.
English: ViraferonPeg 50 micrograms powder and solvent for solution for injection in pre-filled pen peginterferon alfa-2b
Icelandic: ViraferonPeg 50 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna peginterferon alfa-2b
English: BATCH NUMBER
Icelandic: Skammtastærð
English: Each pre-filled pen provides 50 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Hver áfylltur lyfjapenni gefur 50 míkróg/0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: *, injection site inflammation, fatigue, asthenia, irritability, chills, pyrexia, influenza like illness, pain
Icelandic: *, bólga á stungustað, þreyta, slen, erting, kuldahrollur, hiti, inflúensulík veikindi, verkur
English: If your doctor prescribes this medicine with ribavirin or with ribavirin and boceprevir, please read the Package Leaflets of ribavirin and boceprevir before you begin combination treatment.
Icelandic: Lesa skal fylgiseðil fyrir ríbavírin og boceprevír áður en samsett meðferð er hafin ef læknirinn hefur ávísað lyfinu með ríbavírini eða ríbavírini og boceprevíri.
English: With one hand, pinch a fold of loose skin.
Icelandic: Hvolfdu hettuglasinu og sprautunni með annarri hendinni.
English: Bone pain, muscle weakness
Icelandic: Beinverkir, vöðvaslappleiki
English: Each pre-filled pen provides 100 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Icelandic: Hver áfylltur lyfjapenni gefur 100 míkróg/0,5 ml af peginterferon alfa-2b eftir blöndun samkvæmt ráðleggingum.
English: ViraferonPeg 100 micrograms powder and solvent for solution for injection in pre-filled pen peginterferon alfa-2b
Icelandic: ViraferonPeg 100 míkróg stungulyfsstofn og leysir, lausn í áfylltum lyfjapenna peginterferon alfa-2b
English: Dysgeusia, syncope, disturbance in attention, somnolence, poor quality sleep
Icelandic: Breytt bragðskyn, yfirlið, athyglisbrestur, svefnhöfgi, lélegur svefn
English: 8 cleansing swabs; - 12 pre-filled pens (CLEARCLICK) containing powder and solvent for solution for injection, 12 needles ("Push-On Needle"),
Icelandic: - 12 áfylltir lyfjapennar (CLEARCLICK) sem innihalda stungulyfsstofn og leysi, lausn, 12 nálar („Nál sem þrýst er á pennann“),24 hreinsiþurrkur.
English: Tabulated summary of adverse reactions
Icelandic: Ráðlagður skammtur af ViraferonPeg mældur
English: • The need for intake of the 15 mg and 20 mg tablets with food
Icelandic: Nauðsyn þess að taka 15 mg og 20 mg töflur inn með mat
English: • The educational pack is aimed at increasing awareness about the potential risk of bleeding during treatment with Xarelto and providing guidance on how to manage that risk.
Icelandic: Markmið fræðsluefnisins er að auka meðvitund um hugsanlega hættu á blæðingum við Xarelto meðferð og gefa leiðbeiningar um hvernig á að takmarka áhættuna.
English: The need for intake of the 15 mg and 20 mg tablets with food Necessity to carry the Patient alert card with them at all times The need to inform Health Care Professionals that they are taking Xarelto if they need to have any surgery or invasive procedure.
Icelandic: Nauðsyn þess að taka 15 mg og 20 mg töflur inn með mat Nauðsyn þess að bera Öryggiskort fyrir sjúklinga ávallt á sér Nauðsyn þess að upplýsa heilbrigðisstarfsmann um að þeir séu að taka Xarelto þurfi þeir að gangast undir skurðaðgerð eða inngrip
English: • Necessity to carry the Patient alert card with them at all times
Icelandic: Nauðsyn þess að bera Öryggiskort fyrir sjúklinga ávallt á sér
English: • Signs or symptoms of bleeding and when to seek attention from a health care provider.
Icelandic: Merki eða einkenni um blæðingu og hvenær leita á til heilbrigðisstarfsfólks
English: • The need to inform Health Care Professionals that they are taking Xarelto if they need to have any surgery or invasive procedure.
Icelandic: Nauðsyn þess að upplýsa heilbrigðisstarfsmann um að þeir séu að taka Xarelto þurfi þeir að gangast undir skurðaðgerð eða inngrip